To effectively address this health burden, it is imperative to precisely evaluate and understand various tumor attributes, including critical factors such as the KRAS mutation status, tumor staging, and the presence of extramural venous invasion (EMVI) [1]. The gene discussed is KRAS; the disease is neoplasm.